These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 331478

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Allomaron in hyperuricemia and gout].
    Barsom S.
    ZFA (Stuttgart); 1979 Aug 31; 55(24):1336-40. PubMed ID: 539082
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The effect on uric acid and other laboratory parameters. A long-term study].
    Dorn M.
    ZFA (Stuttgart); 1982 Feb 20; 58(5):296-300. PubMed ID: 7043937
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
    Matzkies F, Berg G.
    Dtsch Med Wochenschr; 1976 Oct 22; 101(43):1568-70. PubMed ID: 991731
    [Abstract] [Full Text] [Related]

  • 9. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
    Fortschr Med; 1979 May 03; 97(17):835-6. PubMed ID: 437646
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Gout. Clinical aspects, pathogenesis, current treatment].
    Galmiche P.
    Cah Med; 1971 Apr 30; 12(6):403-13. PubMed ID: 4934051
    [No Abstract] [Full Text] [Related]

  • 12. [Modern therapy of gout].
    Delbarre F, Saporta L, De Gery A, Panahi F.
    Clin Ter; 1968 Jul 31; 46(2):103-22. PubMed ID: 5704842
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A.
    Arthritis Rheum; 2002 Aug 31; 47(4):356-60. PubMed ID: 12209479
    [Abstract] [Full Text] [Related]

  • 17. [A new drug therapy for gout and hyperuricemia. Long term results].
    Masbernard A, Giudicelli CP.
    Sem Hop Ther; 1976 Aug 31; 52(7-8):369-74. PubMed ID: 996556
    [No Abstract] [Full Text] [Related]

  • 18. Benzbromarone therapy in hyperuricaemia; comparison with allopurinol and probenecid.
    Schepers GW.
    J Int Med Res; 1981 Aug 31; 9(6):511-5. PubMed ID: 7033016
    [Abstract] [Full Text] [Related]

  • 19. [Combination of allopurinol and benziodarone in prolonged treatment of hyperuricemia due to chronic renal insufficiency].
    Bianchi Porro G, Petrillo M, Bianchessi M.
    Minerva Med; 1972 Mar 07; 63(17):1000-9. PubMed ID: 5016057
    [No Abstract] [Full Text] [Related]

  • 20. [Pathogenesis and treatment of fast-induced hyperuricemia using benzbromarone].
    Schräpler P, Schulz E.
    Med Welt; 1976 Mar 19; 27(12):575-81. PubMed ID: 1263801
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.